EBP

European Board of Paediatrics

About

UEMS

 

The European Board of Paediatrics (EBP) is the Executive of the Paediatric Section of the UEMS (UEMS-SP), and so is formally part of the UEMS. It sits within the European Academy of Paediatrics, but has to follow the Statutes and rules of the UEMS and this is important especially in terms of voting and decisions made by the Board.

 

The key role of EBP is to harmonize and maintain the highest possible standards of training in Paediatrics across Europe and one of the primary outputs from the Board is therefore European Training Requirements (ETRs) which list the syllabus, trainee assessment methodology, and trainer and training centre requirements.

These ETRs are developed within jointly between the EBP and European specialist societies, and once complete are voted on at a General Assembly meeting of the EBP. They are then submitted to a council meeting of the UEMS for adoption at which time they are officially recognised.

The EBP is also involved in other activities related to the UEMS. We have a major role in developing exams (especially in ‘core’ Paediatrics as specialist exams are often developed within the specialty groups) and are responsible for overseeing training centre visits and accreditation.

We also coordinate paediatric presence on Multidisciplinary Joint Committees (MJCs) that are set up by the UEMS to address training issues in emerging areas that fall between different sections of the UEMS. As the UEMS-SP we are entitled to request representation on such committees – as are national bodies and specialist societies.

Another aspect of EBP activity is to provide ‘Continuing Medical Education’ accreditation for international conferences and meetings.

The Officers of the EBP include the Chairperson (who is ex officio Vice-President of EAP), the EBP Treasurer and other persons that EBP may co-opt, including a lead for examinations, and a training accreditation lead.

The EBP General Assembly – which is dealing with UEMS issues – is also governed by their rules and statutes. This requires the voting to be confined to UEMS National Delegates only (one country, one vote) and other delegates (such as sub-specialty liaison officers) are not able to take part in the formal vote, although are of course very involved in the discussions and preparation of the ETRs. As the list of countries included within UEMS is different from the more expanded list of countries within the EAP, the two General Assemblies (EAP and EBP) are separated from each other and have different agenda.

The constructive collaboration and integration of EBP, within UEMS, with EAP and Paediatric sub-specialties Societies are the key to the improvement of the quality of training and patient care for neonate, children and adolescent all over Europe.

Agendas

Minutes

close menu icon

Your Enquiries Are Welcome

We will respond to you by Email

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative:

  • BERTHOLD KOLETZKO
Read more